Jay Olson
Equity research analyst · Oppenheimer
Earnings calls
1
Nov 12, 2026 – Nov 12, 2026
Stocks asked about
1
Questions
1
Firm rating actions
0
on these stocks, from news
Coverage
Companies whose earnings calls Jay Olson asked questions on (from Lician's transcripts).
Questions on earnings calls
- NKTR earnings call · NEKTAR THERAPEUTICSNov 12, 2026 · 1 question
- 45:09
“Oh, hey, congrats on all the progress across so many different clinical development programs. And thanks for taking the question. Since your work at EADV linked early increases in IL-10 and T. EGF-beta-1 changes to subsequent clinical improvement, are you also looking at whether…”
- 45:09
Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.
Oppenheimer rating actions on these stocks
From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Jay Olson. We do not use licensed rating databases.
No rating action by Oppenheimer on these stocks in the headlines we store yet.